Literature DB >> 31732290

Serum creatinine to cystatin C ratio predicts skeletal muscle mass and strength in patients with non-dialysis chronic kidney disease.

Yu-Li Lin1, Shu-Yuan Chen2, Yu-Hsien Lai3, Chih-Hsien Wang4, Chiu-Huang Kuo5, Hung-Hsiang Liou6, Bang-Gee Hsu7.   

Abstract

BACKGROUND & AIMS: Muscle wasting is highly prevalent in patients with chronic kidney disease (CKD). However, the assessment of skeletal muscle mass and strength in clinical settings is not commonly available. We aimed to evaluate the feasibility of serum creatinine/cystatin C (Cr/CysC) ratio in the assessment of muscle wasting.
METHODS: In 272 patients with CKD aged 66.5 ± 15.1 years, skeletal muscle mass and handgrip strength (HGS) were assessed. Skeletal muscle index (SMI) was calculated as skeletal muscle mass/height2. Low muscle mass was defined as SMI below the sex-specific 10th percentile of study population and low handgrip strength as less than 26 Kg for men and 18 Kg for women.
RESULTS: The Cr/CysC ratio was significantly lower in both the low SMI and low HGS groups. Moreover, the Cr/CysC ratio correlated with SMI (r = .306, p < .001) and HGS (r = .341, p < .001). After adjusting for confounding factors, age, sex, waist circumference, body fat mass, and Cr/CysC ratio were independently associated with SMI, whereas age, sex, diabetes, hemoglobin, estimated glomerular filtration rate, urine protein/creatinine ratio, SMI, and Cr/CysC ratio were independently associated with HGS.
CONCLUSIONS: Cr/CysC ratio appears to be a promising surrogate marker for detecting muscle wasting in patients with CKD. Further studies are needed to extend our findings.
Copyright © 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease; Creatinine; Cystatin C; Muscle wasting; Sarcopenia

Year:  2019        PMID: 31732290     DOI: 10.1016/j.clnu.2019.10.027

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  19 in total

1.  Associations Between Surrogates of Skeletal Muscle Mass and History of Bone Fracture in Patients with Chronic Kidney Disease: The Fukuoka Kidney disease Registry (FKR) Study.

Authors:  Shunsuke Yamada; Shigeru Tanaka; Hokuto Arase; Hiroto Hiyamuta; Eriko Yoshizumi; Masanori Tokumoto; Toshiaki Nakano; Kazuhiko Tsuruya; Takanari Kitazono
Journal:  Calcif Tissue Int       Date:  2021-04-27       Impact factor: 4.333

2.  Normalized Creatinine-to-Cystatin C Ratio and Risk of Diabetes in Middle-Aged and Older Adults: The China Health and Retirement Longitudinal Study.

Authors:  Shanhu Qiu; Xue Cai; Bo Xie; Yang Yuan; Zilin Sun; Tongzhi Wu
Journal:  Diabetes Metab J       Date:  2022-03-07       Impact factor: 5.893

3.  Sarcopenia HIBA score predicts sarcopenia and mortality in patients on the liver transplant waiting list.

Authors:  Ezequiel Mauro; Juan Manuel Diaz; Lucrecia Garcia-Olveira; Juan Carlos Spina; Lorena Savluk; Fernanda Zalazar; Julia Saidman; Martin De Santibañes; Juan Pekolj; Eduardo De Santibañes; Gonzalo Crespo; Juan G Abraldes; Adrían Gadano
Journal:  Hepatol Commun       Date:  2022-03-03

4.  Serum Creatinine to Cystatin C Ratio is an Effective Indicator for Muscle Strength Decline in Men with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Dan Huang; Canhui Xie; Chaoqun Sun; Min Chen; Lian Li; Huajuan Yi; Jinyu Liao; Xuanna Zhao; Xiaoping Shen; Donglan He; Dongming Li; Dong Wu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-04-08

5.  Sarcopenia in Non-Dialysis Chronic Kidney Disease Patients: Prevalence and Associated Factors.

Authors:  Geraldo José de Amorim; Cinthia Katiane Martins Calado; Bruno Carlos Souza de Oliveira; Renata Patricia Oliveira Araujo; Tayrine Ordonio Filgueira; Matheus Santos de Sousa Fernandes; Angela Castoldi; Gisele Vajgel; Lucila Maria Valente; José Luiz de Lima-Filho; Paulo Roberto Cavalcanti Carvalho; Fabricio Oliveira Souto
Journal:  Front Med (Lausanne)       Date:  2022-04-07

6.  Cre/CysC ratio may predict muscle composition and is associated with glucose disposal ability and macrovascular disease in patients with type 2 diabetes.

Authors:  Qing Yang; Mei Zhang; Peng Sun; Yanying Li; Huichao Xu; Kejun Wang; Hongshan Shen; Bo Ban; Fupeng Liu
Journal:  BMJ Open Diabetes Res Care       Date:  2021-11

7.  Late stage 3 chronic kidney disease is an independent risk factor for sarcopenia, but not proteinuria.

Authors:  Jung Nam An; Jwa-Kyung Kim; Hyung-Seok Lee; Sung Gyun Kim; Hyung Jik Kim; Young Rim Song
Journal:  Sci Rep       Date:  2021-09-16       Impact factor: 4.379

8.  A Novel Application of Serum Creatinine and Cystatin C to Predict Sarcopenia in Advanced CKD.

Authors:  Yu-Li Lin; Chih-Hsien Wang; I-Chen Chang; Bang-Gee Hsu
Journal:  Front Nutr       Date:  2022-02-25

9.  Cystatin C- and Creatinine-Based Glomerular Filtration Rate Estimation Differences and Muscle Quantity and Functional Status in Older Adults: The Health, Aging, and Body Composition Study.

Authors:  O Alison Potok; Joachim H Ix; Michael G Shlipak; Nisha Bansal; Ronit Katz; Stephen B Kritchevsky; Dena E Rifkin
Journal:  Kidney Med       Date:  2022-01-25

10.  Serum creatinine to cystatin C ratio reflects preoperative and early postoperative walking ability in older patients with hip fracture.

Authors:  Naoki Okubo; Takashi Yoshida; Kazuya Tanaka; Naoya Okada; Kunihiko Hosoi; Masato Ohara; Kenji Takahashi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-02-15       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.